Page 188 - Read Online

Page 16 of 16 Borzio et al. Hepatoma Res 2019;5:15 I http://dx.doi.org/10.20517/2394-5079.2019.11

on 26 Apr 2019]
70. Terzi E, Iavarone M, Pompili M, Veronese L, Cabibbo G, et al. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma
in cirrhosis in a multicenter restropective study of 1,006 nodules J Hepatol 2018;68:485-92.
71. Kondo F, Ebara M, Sugiura N, Wada K, Kita K, et al. Histological features and clinical course of large regenerative nodules:
evaluation of their precancerous potentiality. Hepatology 1990;12:592-8.
72. Terasaki S, Kaneko S, Kobayashi K, Nonomura A, Nakanuma Y. Histological features predicting malignant transformation of
nonmalignant hepatocellular nodules: a prospective study. Gastroenterology 1998;115:1216-22.
73. Seki S, Sakaguchi H, Kitada T, Tamori A, Takeda T, et al. Outcomes of dysplastic nodules in human cirrhotic liver: a
clinicopathological study. Clin Cancer Res 2000;6:3469-73.
74. Kobayashi M, Ikeda K, Hosaka T, Sezaki H, Someya T, et al. Dysplastic nodules frequently develop into hepatocellular carcinoma in
patients with chronic viral hepatitis and cirrhosis. Cancer 2006;106:636-47.
75. Sato T, Kond Fo, Ebara M, Sugiura N, Okab Se, et al, Natural history of large regenerative nodules and dysplastic nodules in liver
cirrhosis: 28-year follow-up study. Hepatol Int 2015;9:330-6.
76. Iavarone M, Manini MA, Sangiovanni A, Fraquelli M, Forzenigo LV, et al. Contrast-enhanced computed tomography and ultrasound-
guided liver biopsy to diagnose dysplastic liver nodules in cirrhosis. Dig Liv Dis 2013;45:43-9.
77. Takayasu K, Muramatsu Y, Mizuguchi Y, Ojima H. CT imaging of early hepatocellular carcinoma and the natural outcome of
hypoattenuating nodular lesions in chronic liver disease. Oncology 2007;72 Suppl:83-91.
78. Chung JJ, Yu JS, Kim JH, Kim MJ, Kim KW. Nonhypervascular hypoattenuating nodules depicted on either portal or equilibrium
phase multiphasic CT images in the cirrhotic liver. Am J Roentgenol 2008;191:207-14.
79. Chuo HJ, Kim B, Lee JD, Kang DR, Kim JK, et al. Development of risk prediction model for hepatocellular carcinoma progression of
indeterminate nodules in hepatitis B virus-related cirrhotic liver. Am J Gastroenterol 2017;112:460-70.
80. Motosugi U, Ichikawa T, Sano K, Sou H, Onohara K, et al. Outcome of hypovascular hepatic nodules revealing no gadoxetic acid
uptake in patients with chronic liver disease. J Magn Reson Imaging 2011;34:88-94.
81. Kumada T, Toyoda H, Tada T, Sone J, Fusijmori M, et al. Evolution of hypointense hepatocellular nodules observed only in the
hepatobiliary phase ofgadoxetate disodium-enhanced MRI. AJR Am JRoentgenol 2011;197:58-63.
82. Hyodo T, Murakami T, Imai Y, Okada M, Hori M, et al. Hypovascular nodules in patients with chronic liver disease: risk factors for
development of hypervascular hepatocellular carcinoma. Radiology 2013;266:480-90.
83. Kim YK, Lee WJ, Park MJ, Kim SH, Rhim H, et al. Hypovascular hypointense nodules on hepatobiliary phase gadoxetic acid-
enhanced MR images in patients with cirrhosis: potential of DW imaging in predicting progression to hypervascular HCC. Radiology
2012;265:104-14.
84. Higaki A, Ito K, Tamada T, Sone T, Kanki A, et al. Prognosis of small hepatocellular nodules detected only at the hepatobiliary phase
of Gd-EOB-DTPA-enhanced MR imaging as hypointensity in cirrhosis or chronic hepatitis. Eur Radiol 2014;24:2476-81.
85. Kim YS, Song JS, Lee HK, Han YM. Hypovascular hypointense nodules on hepatobiliary phase without T2 hyperintensity on
gadoxetic acid-enhanced MR images in patients with chronic liver disease: long-term outcomes and risk factors for hypervascular
transformation. Eur Radiol 2016;26:3728-36.
86. Sano K, Ichikawa T, Motosugi U, Ichikawa S, Morisaka H, et al. Outcome of hypovascular hepatic nodules with positive uptake of
gadoxetic acid in patients with cirrhosis. Eur Radiol 2017;27:518-25.
87. Kojiro M. Focus on dysplastic nodules and early hepatocellular carcinoma: an eastern point of view. Liver Transpl 2004;10:S3-8.
88. Kim SH, Lim HK, Kim MJ, Choi D, Rhim H, et al. Radiofrequency ablation of high-grade dysplastic nodules in chronic liver disease:
comparison with well-differentiated hepatocellular carcinoma based on long-term results. Eur Radiol 2008;18:814-21.
89. Cho YK, Wook Chung J, Kim Y, Je Cho H, Hyun Yang S. Radiofrequency ablation of high-grade dysplastic nodules. Hepatology
2011;54:2005-11.
90. John VB, Khalili K. Not all nodules are created equal: a personalized approach to indeterminate (< 2 cm) nodules identified on HCC
surveillance. Am J Gastroenterol 2017;112:471-2.